ES2090934T3 - Nuevos derivados de beta-aminoacidos con actividad antitrombotica. - Google Patents

Nuevos derivados de beta-aminoacidos con actividad antitrombotica.

Info

Publication number
ES2090934T3
ES2090934T3 ES93810172T ES93810172T ES2090934T3 ES 2090934 T3 ES2090934 T3 ES 2090934T3 ES 93810172 T ES93810172 T ES 93810172T ES 93810172 T ES93810172 T ES 93810172T ES 2090934 T3 ES2090934 T3 ES 2090934T3
Authority
ES
Spain
Prior art keywords
beta
amino acids
new derivatives
antithrombotic activity
antithrombotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93810172T
Other languages
English (en)
Spanish (es)
Inventor
Georg Kottirsch
Rainer Metternich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of ES2090934T3 publication Critical patent/ES2090934T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Materials For Medical Uses (AREA)
ES93810172T 1992-03-10 1993-03-08 Nuevos derivados de beta-aminoacidos con actividad antitrombotica. Expired - Lifetime ES2090934T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4207544 1992-03-10

Publications (1)

Publication Number Publication Date
ES2090934T3 true ES2090934T3 (es) 1996-10-16

Family

ID=6453662

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93810172T Expired - Lifetime ES2090934T3 (es) 1992-03-10 1993-03-08 Nuevos derivados de beta-aminoacidos con actividad antitrombotica.

Country Status (26)

Country Link
US (1) US5561112A (en:Method)
EP (1) EP0560730B1 (en:Method)
JP (1) JP2860222B2 (en:Method)
KR (1) KR930019690A (en:Method)
CN (1) CN1076200A (en:Method)
AT (1) ATE142618T1 (en:Method)
AU (1) AU659281B2 (en:Method)
CA (1) CA2091292A1 (en:Method)
CZ (1) CZ36193A3 (en:Method)
DE (1) DE69304573T2 (en:Method)
DK (1) DK0560730T3 (en:Method)
ES (1) ES2090934T3 (en:Method)
FI (1) FI931023L (en:Method)
GR (1) GR3021030T3 (en:Method)
HU (2) HUT63609A (en:Method)
IL (1) IL104972A (en:Method)
MX (1) MX9301298A (en:Method)
MY (1) MY109060A (en:Method)
NO (1) NO300778B1 (en:Method)
NZ (1) NZ247084A (en:Method)
PH (1) PH30893A (en:Method)
RU (1) RU2106356C1 (en:Method)
SG (1) SG47059A1 (en:Method)
SK (1) SK17093A3 (en:Method)
TW (1) TW256828B (en:Method)
ZA (1) ZA931724B (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692438B2 (en) * 1993-03-29 1998-06-11 Astrazeneca Ab Heterocyclic derivatives as platelet aggregation inhibitors
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
WO1994022835A2 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
US5811398A (en) * 1995-04-11 1998-09-22 G. D. Searle & Co. Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues
EP0892780B1 (en) * 1996-02-22 2002-11-20 Bristol-Myers Squibb Pharma Company M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
US5942544A (en) * 1996-02-22 1999-08-24 Dupont Pharmaceuticals Company α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors
RU2142939C1 (ru) * 1996-10-28 1999-12-20 Эл Джи Кемикал Лтд. Избирательно действующие ингибиторы тромбина и фармацевтическая композиция на их основе
EP1478405A2 (en) * 2002-01-28 2004-11-24 Novartis AG Beta-homolysine conjugates and their use as transport enhancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
WO1988007867A1 (en) * 1987-04-08 1988-10-20 Nippon Shinyaku Co., Ltd. Nootropic
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
US5273982A (en) * 1990-03-09 1993-12-28 Hoffmann-La Roche Inc. Acetic acid derivatives
US5354738A (en) * 1992-09-04 1994-10-11 G. D. Searle & Co. Platelet aggregation inhibitors

Also Published As

Publication number Publication date
GR3021030T3 (en) 1996-12-31
PH30893A (en) 1997-12-23
HU210878A9 (en) 1995-09-28
CZ36193A3 (en) 1994-01-19
HUT63609A (en) 1993-09-28
EP0560730A3 (en) 1993-12-01
AU3406993A (en) 1993-09-16
FI931023A7 (fi) 1993-09-11
IL104972A (en) 1998-04-05
NO930830L (no) 1993-09-13
HU9300501D0 (en) 1993-05-28
JP2860222B2 (ja) 1999-02-24
ATE142618T1 (de) 1996-09-15
DE69304573T2 (de) 1997-03-20
EP0560730A2 (en) 1993-09-15
MX9301298A (es) 1993-10-01
AU659281B2 (en) 1995-05-11
ZA931724B (en) 1994-09-10
FI931023L (fi) 1993-09-11
JPH0665175A (ja) 1994-03-08
MY109060A (en) 1996-11-30
CA2091292A1 (en) 1993-09-11
KR930019690A (ko) 1993-10-18
DE69304573D1 (de) 1996-10-17
EP0560730B1 (en) 1996-09-11
SK17093A3 (en) 1993-10-06
DK0560730T3 (da) 1996-10-28
FI931023A0 (fi) 1993-03-08
NO300778B1 (no) 1997-07-21
RU2106356C1 (ru) 1998-03-10
IL104972A0 (en) 1993-07-08
CN1076200A (zh) 1993-09-15
SG47059A1 (en) 1998-03-20
NZ247084A (en) 1995-09-26
US5561112A (en) 1996-10-01
NO930830D0 (no) 1993-03-08
TW256828B (en:Method) 1995-09-11

Similar Documents

Publication Publication Date Title
ES2090934T3 (es) Nuevos derivados de beta-aminoacidos con actividad antitrombotica.
MX9301751A (es) Acidos amido peroxicarboxilicos.
DE59709414D1 (de) Oxyiminopregnancarbolactone
ATE215102T1 (de) Wässerige dispersionen enthaltend polyurethane mit carbodiimidgruppen
IT8919413A0 (it) Composizione avente attivita' battericida oppure batteriostatica.
IT1247945B (it) Agente avente attivita' batteriostatica e battericida
BR9405351A (pt) Ação combinada de endoglucanases e celobioidrolases
ES2016920A4 (es) Procedimiento de realizacion de barras anti-torsion por encolado in situ de cojinetes elasticos y barras anti-torsion realizadas segun el procedimiento.
ES2157523T3 (es) Solucion de dialisis peritoneal.
FI945164A7 (fi) Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina
ATE90359T1 (de) Peptide.
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
ATE302757T1 (de) Neue polyzyklische indanylimidazole mit alpha2 adrenergik aktivität
BR9702075A (pt) Derivados de uréida biologicamente ativos úteis no tratamento de esclerose múltipla
ES2138653T3 (es) Eteres fenilicos substituidos.
MX9504335A (es) Uso de la sal de amina dietilica de ceruletida en el tratamiento de la psoriasis.
ES2086449T3 (es) 2-terbutil-4-cloro-5-(4-ibutilmetilciclohexil)-metiltio-3(h)-piridazinona con actividad acaricida e insecticida.
SU1826482A1 (ru) Хлорид 2-хлормеркурметил-2,3-дигидро-5,5-диоксо-5-тиаоксазолино[2,3-а] изоиндолиния, обладающий противомикробной активностью
KR950005387U (ko) 신체에 착용하는 정전기 발생장치
SE9302341D0 (sv) Cellproliferationshaemmande medel
ITTO930655A0 (it) Urologica realizzazione sintetica dell'epidimo testicolare
IT8485542A0 (it) Casa mobile con vano abitabile estraibile dalla scocca.
ITMI920246A1 (it) Derivati chinolonici in forma di enantiomeri ad elevata attivita' antibatterica

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 560730

Country of ref document: ES

FG2A Definitive protection

Ref document number: 560730

Country of ref document: ES